Alexion to Present at the Bank of America Merrill Lynch 2016 Health Care Conference

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Hazardous Drug Compounding: The Safety Standards Behind Every Prescription

Quick Answer Hazardous drug compounding is the careful preparation of...

US Details Eligibility for Section 232 Specialty Pharmaceutical Tariff Exemptions

The Trump administration has released detailed guidance regarding specialty...
- Advertisement -

Alexion Pharmaceuticals, Inc announced that management will present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas on Tuesday, May 10, 2016 at 10:40 a.m., Pacific Time.

An audio webcast of the presentation will be available live. You can access the webcast at: http://ir.alexionpharm.com. An archived version of the remarks will also be available through the Company’s web site for a limited time following the conference.

 

Contact:

Alexion Pharmaceuticals, Inc.
Elena Ridloff, CFA
Vice President, Investor Relations
(203) 699-7722

 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

Hazardous Drug Compounding: The Safety Standards Behind Every Prescription

Quick Answer Hazardous drug compounding is the careful preparation of...

US Details Eligibility for Section 232 Specialty Pharmaceutical Tariff Exemptions

The Trump administration has released detailed guidance regarding specialty...

Top Small Molecule API Partners for 2026

Choosing a small-molecule API manufacturing partner affects cost and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »